|
End-of-day quote
Korea S.E.
10/09/2026
|
5-day change | 1st Jan Change | ||
| 53,100.00 KRW | -1.30% |
|
-2.57% | -55.75% |
| 08-23 | Orum Therapeutics Receives FDA Clearance Of IND Application For ORM-1153, A Novel CD123-GSPT1 Degrader-Antibody Conjugate | CI |
| 07-15 | Alert wrongly tagged to Orum Therapeutics withdrawn | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.30% | -2.57% | -24.03% | -17.16% | -55.75% | +64.14% | - | - | - | 857M | |
| -0.25% | -1.36% | -4.24% | +59.21% | +70.45% | +44.08% | +102.76% | +9.73% | - | 68.24B | |
| -0.65% | -4.86% | +13.51% | +9.62% | +18.61% | +29.84% | +72.91% | +209.28% | +5,816.49% | 62.23B | |
| -1.18% | +0.47% | -5.54% | +38.53% | -26.87% | -12.78% | +384.69% | +368.80% | +865.71% | 27.8B | |
| -1.98% | -5.33% | +1.26% | +55.51% | +48.09% | +29.33% | +9.04% | -59.58% | - | 24.86B | |
| -1.76% | -6.30% | +3.88% | +11.90% | +1.26% | -4.55% | -19.75% | -72.39% | - | 24.22B | |
| -0.86% | -5.19% | +4.57% | +29.54% | +2.76% | +17.75% | -20.95% | -25.15% | +108.30% | 19.36B | |
| -1.86% | -2.22% | -0.75% | +48.50% | +211.54% | +202.03% | +353.89% | +1,608.64% | +792.81% | 17.28B | |
| -1.81% | -4.82% | -11.86% | +18.10% | +18.77% | -5.17% | +496.41% | - | - | 14.46B | |
| -1.54% | -2.88% | +8.44% | +9.22% | +31.03% | +52.33% | +159.75% | +187.73% | +379.38% | 14.23B | |
| -3.08% | -0.76% | +14.32% | +30.27% | -2.80% | -3.44% | +1,003.90% | +161.54% | +175.08% | 13.56B | |
| -2.48% | -1.75% | +3.45% | +13.11% | -8.45% | +23.95% | +171.20% | +565.40% | +4,715.90% | 12.32B | |
| +0.16% | -4.31% | -6.31% | +17.01% | +24.66% | +186.47% | +176.79% | +29.33% | +1,055.87% | 11.69B | |
| -2.88% | -10.13% | -10.75% | +3.59% | -19.51% | -28.78% | +146.81% | +113.25% | - | 11B | |
| -0.66% | -0.45% | -4.99% | +9.77% | +15.86% | +41.58% | +104.16% | +149.39% | +709.90% | 10.23B | |
| -1.03% | -3.71% | +1.05% | +29.68% | +27.65% | +84.06% | +16.22% | +125.15% | - | 8.76B | |
| -4.22% | -5.74% | +3.07% | +10.60% | +289.90% | +200.39% | +498.45% | -21.94% | - | 8.18B | |
| -0.74% | -7.88% | -11.95% | +5.81% | +2.36% | -34.02% | +95.23% | -27.96% | - | 7.98B | |
| +2.05% | +1.67% | -15.78% | +18.15% | +170.79% | +448.27% | +533.64% | -47.89% | -48.94% | 7.82B | |
| -4.42% | +2.33% | +4.67% | +28.14% | +9.45% | +164.18% | +455.60% | - | - | 7.05B | |
| Average | -1.26% | -2.64% | -1.90% | +21.46% | +41.49% | +74.98% | +249.51% | +192.55% | +1,457.05% | 18.61B | |
| Weighted average by Cap. | -1.10% | -2.74% | +0.99% | +29.05% | +40.17% | +51.04% | +188.51% | +180.92% | +2,477.68% |
- Stock Market
- Stocks
- A475830 Stock
- Sector Orum Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
